focus -WSS

focus

author：Wikipedia 2025-09-29 22:52:23 - browse：5187

the U.S. Medicare Handbook is photographed in Washington. — Pablo Martinez Monsivais/AP

Roughly 33.4 million adults older than 65 and people with disabilities were enrolled in a Medicare Advantage plan as the calendar flipped to 2024 — another year of steady, albeit slower, growth for the taxpayer-funded program.

Enrollment increased 7.1% year over year, which would make this year’s annual growth rate identical to last year’s, according to new federal Medicare Advantage enrollment data analyzed by STAT.

The data reinforce how America’s Medicare program continues to shift toward a more privatized version that has not saved any money for taxpayers, has been linked to inappropriate coding practices, and has restricted care for older and vulnerable patients. And even though the federal government made several changes to Medicare Advantage for 2024 — changes that were vehemently opposed by the health insurance industry — the program’s growth has not been stunted, nor did insurers dramatically slash their offerings.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： A Q&A with the global head of Boehringer Ingelheim's innovation unit

hotspot

WSS

FDA panel signals lack of confidence in Amgen cancer drug data

Analysis of telehealth claims data suggest service duplication

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

iTeos Therapeutics debuts first data on TIGIT

Chemotherapy drug shortage eases slightly but still widespread

Akili, maker of video game for ADHD, to be acquired for 34 million

entertainment

focus

focus

Anesthesiologist group: stop taking Ozempic before surgery

Was Amgen transparent enough on FDA's concern on cancer drug?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Do more moles mean more problems? Not so, says new study

Hollywood unions extend contract negotiations for actors

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

In age of alternative facts, a scholarly course on calling out crap

Chemotherapy drug shortage eases slightly but still widespread

In age of alternative facts, a scholarly course on calling out crap

Biohaven protein

hotspot

Stroke deaths set to near 10 million globally by 2050

What to expect at HLTH 2023, the health care industry conference

Why Charlie Gard's case is so disturbing to Americans

Focused ultrasound for uterine fibroids: an uphill battle

What to expect at HLTH 2023, the health care industry conference

Lab trade group sues FDA to halt regulation of lab

Wikipedia

hotspot

hotspot

entertainment